Joseph Saluri - Net Worth and Insider Trading

Joseph Saluri Net Worth

The estimated net worth of Joseph Saluri is at least $7,774 dollars as of 2024-11-13. Joseph Saluri is the Director of Lumos Pharma Inc and owns about 1,783 shares of Lumos Pharma Inc (LUMO) stock worth over $7,774. Details can be seen in Joseph Saluri's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Joseph Saluri has not made any transactions after 2015-07-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Joseph Saluri

To

Joseph Saluri Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Joseph Saluri owns 3 companies in total, including Zevra Therapeutics Inc (ZVRA) , Cibus Inc (CBUS) , and Lumos Pharma Inc (LUMO) .

Click here to see the complete history of Joseph Saluri’s form 4 insider trades.

Insider Ownership Summary of Joseph Saluri

Ticker Comapny Transaction Date Type of Owner
ZVRA Zevra Therapeutics Inc 2015-04-15 director
CBUS Cibus Inc 2017-07-20 General Counsel & EVP-Corp Dev
LUMO Lumos Pharma Inc 2015-07-13 director

Joseph Saluri Latest Holdings Summary

Joseph Saluri currently owns a total of 1 stock. Joseph Saluri owns 1,783 shares of Lumos Pharma Inc (LUMO) as of July 13, 2015, with a value of $7,774.

Latest Holdings of Joseph Saluri

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
LUMO Lumos Pharma Inc 2015-07-13 1,783 4.36 7,774

Holding Weightings of Joseph Saluri


Joseph Saluri Form 4 Trading Tracker

According to the SEC Form 4 filings, Joseph Saluri has made a total of 0 transactions in Lumos Pharma Inc (LUMO) over the past 5 years. The most-recent trade in Lumos Pharma Inc is the sale of 556 shares on July 13, 2015, which brought Joseph Saluri around $252,100.

Insider Trading History of Joseph Saluri

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Joseph Saluri Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Joseph Saluri Ownership Network

Ownership Network List of Joseph Saluri

No Data

Ownership Network Relation of Joseph Saluri

Insider Network Chart

Joseph Saluri Owned Company Details

What does Zevra Therapeutics Inc do?

Who are the key executives at Zevra Therapeutics Inc?

Joseph Saluri is the director of Zevra Therapeutics Inc. Other key executives at Zevra Therapeutics Inc include VP Fin & Corp Controller R. Laduane Clifton , director & President and CEO Neil F. Mcfarlane , and CCO & EVP & Bus. Development Joshua Schafer .

Zevra Therapeutics Inc (ZVRA) Insider Trades Summary

Over the past 18 months, Joseph Saluri made no insider transaction in Zevra Therapeutics Inc (ZVRA). Other recent insider transactions involving Zevra Therapeutics Inc (ZVRA) include a net purchase of 1,500 shares made by Watton Corey Michael , a net purchase of 30,000 shares made by John B Bode , and a net purchase of 5,740 shares made by R. Laduane Clifton .

In summary, during the past 3 months, insiders sold 0 shares of Zevra Therapeutics Inc (ZVRA) in total and bought 500 shares, with a net purchase of 500 shares. During the past 18 months, 0 shares of Zevra Therapeutics Inc (ZVRA) were sold and 58,740 shares were bought by its insiders, resulting in a net purchase of 58,740 shares.

Zevra Therapeutics Inc (ZVRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Zevra Therapeutics Inc Insider Transactions

No Available Data

Joseph Saluri Mailing Address

Above is the net worth, insider trading, and ownership report for Joseph Saluri. You might contact Joseph Saluri via mailing address: C/o Newlink Genetics Corp., 2503 South Loop Dr., Suite 5100, Aimes Ia 50010.